This is a revised application for establishment of a training program in Developmental Hematology in the Department of Pediatrics at Washington University School of Medicine. The program will provide pediatric physicians (M.D.'s or M.D., Ph.D.'s) with postdoctoral research experience with the long-term goal of producing independent investigators capable of making important contributions to biomedical research. Trainees will be second- and third-year fellows recruited from the Hematology-Oncology fellowship program in the Department of Pediatrics at Washington University School of Medicine. This pool of fellows includes many qualified applicants with backgrounds in hematology research. Trainees will participate in a formal seminar series that includes a discussion of current research in developmental hematology, along with didactic sessions in statistics, design of research, and the ethical conduct of research. Trainees may perform their postdoctoral research in a wide range of laboratories at Washington University, provided the research is relevant to the field of developmental hematology. It is anticipated that this award will support two new trainees per year for a duration of two years. Alan L. Schwartz, M.D., Ph.D., will serve as Program Director. The establishment of the proposed program will help to close the gap between basic developmental biologists and pediatric clinicians.

National Institute of Health (NIH)
Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)
Institutional National Research Service Award (T32)
Project #
Application #
Study Section
Special Emphasis Panel (ZHD1-MRG-C (25))
Program Officer
Klein, Steven
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
Washington University
Schools of Medicine
Saint Louis
United States
Zip Code
Monlish, Darlene A; Bhatt, Sima T; Schuettpelz, Laura G (2016) The Role of Toll-Like Receptors in Hematopoietic Malignancies. Front Immunol 7:390
Hall, Erin M; Leonard, Jeffrey; Smith, Jodi L et al. (2016) Reduction in Overt and Silent Stroke Recurrence Rate Following Cerebral Revascularization Surgery in Children with Sickle Cell Disease and Severe Cerebral Vasculopathy. Pediatr Blood Cancer 63:1431-7
Herman, A C; Monlish, D A; Romine, M P et al. (2016) Systemic TLR2 agonist exposure regulates hematopoietic stem cells via cell-autonomous and cell-non-autonomous mechanisms. Blood Cancer J 6:e437
Fields, Melanie E; Hoyt-Drazen, Catherine; Abel, Regina et al. (2016) A pilot study of parent education intervention improves early childhood development among toddlers with sickle cell disease. Pediatr Blood Cancer 63:2131-2138
Liu, Chang; Duffy, Brian; Bednarski, Jeffrey J et al. (2016) Maternal T-Cell Engraftment Interferes With Human Leukocyte Antigen Typing in Severe Combined Immunodeficiency. Am J Clin Pathol 145:251-7
Bednarski, Jeffrey J; Pandey, Ruchi; Schulte, Emily et al. (2016) RAG-mediated DNA double-strand breaks activate a cell type-specific checkpoint to inhibit pre-B cell receptor signals. J Exp Med 213:209-23
Madden, Lisa M; Ngwube, Alexander I; Shenoy, Shalini et al. (2015) Late toxicity of a novel allogeneic stem cell transplant using single fraction total body irradiation for hematologic malignancies in children. J Pediatr Hematol Oncol 37:e94-e101
Fields, Melanie E; Hulbert, Monica L; Chen, Ling et al. (2015) Red blood cell storage duration is not associated with clinical outcomes for acute chest syndrome in children with sickle cell disease. Transfusion 55:2714-21
Sengupta, Rajarshi; Barone, Amy; Marasa, Jayne et al. (2015) Novel chemical library screen identifies naturally occurring plant products that specifically disrupt glioblastoma-endothelial cell interactions. Oncotarget 6:18282-92
Ngwube, Alexander; Hayashi, Robert J; Murray, Lisa et al. (2015) Alemtuzumab based reduced intensity transplantation for pediatric severe aplastic anemia. Pediatr Blood Cancer 62:1270-6

Showing the most recent 10 out of 23 publications